Feline herpesvirus-1: Ocular manifestations, diagnosis and treatment options

• Autorzy: Gould D.

Warianty tytułu

PL

Choroby oczu kotów wywołane zakażeniami herpesvirusem-1: Objawy kliniczne, diagnostyka i sposoby leczenia

• Języki publikacji: EN

Abstrakty

EN

Practical relevance Feline herpesvirus-1 (FHV-1) is a major cause of feline morbidity. Following exposure to the virus, virtually all cats become persistently infected and many of these will develop recrudescent disease on one or more occasions during their life. Ocular manifestations include conjunctivitis, corneal ulceration and keratitis. In severe cases the condition can be blinding. Global importance FHV-1 has a worldwide distribution, with reported exposure rates in some cat populations of up to 97%. As such it is a significant cause of clinical disease in the global cat population. Patient Group Young and adolescent cats are most at risk of acute primary disease, and the vast majority of these will then become persistently infected. Around half of all persistently infected cats will shed virus at some stage in their life and these may develop recrudescent ocular disease. Clinical challenges Acute ocular herpetic disease can be severe and painful. Repeated bouts of recrudescent ocular disease can lead to progressive corneal pathology that can be ultimately blinding in affected cats. Treatment of FHV-1 ocular disease is challenging. Antiviral medications may be expensive and require good owner and patient compliance. Clinical responses in patients can be variable. Selecting the appropriate therapeutic approach requires good clinical judgement and depends on a number of factors such as severity and stage of clinical disease, patient and owner compliance and financial considerations. Evidence base Although a wide range of antiviral treatments are available, very few of these have been tested in controlled clinical trials. Instead, therapeutic decisions are often made based on results of in vitro studies, case-based reports and anecdote. Large, masked, controlled clinical trials are required in order to determine the efficacy of the antiviral drugs currently available to treat FHV-1.

PL

W swojej pracy autor przedstawia kluczowe aspekty związane z chorobami oczu występującymi u kotów, które  powoduje  herpesvirus  koci typu 1. Praca  w obszerny sposób omawia wiele chorób implikowanych tym typem wirusa. szczegółowo opisuje objawy kliniczne poszczególnych schorzeń, diagnostykę oraz doradza w sposób praktyczny dobieranie odpowiedniego leczenia. Mamy podany szereg leków wraz z dawkami i sposobami ich podania dla poszczególnych schematów leczenia. Praca jest bogato ilustrowana fotografiami obrazującymi konkretne przypadki kliniczne. Autor włożył wiele wysiłku, dzięki czemu powstała naprawdę wspaniała praca naukowa, która praktykom daje gotowy schemat rozpoznawania i leczenia tych trudnych z punktu klinicznego chorób.

Słowa kluczowe

EN

cat; animal disease; feline herpesvirus 1; diagnosis; treatment; ocular manifestation; keratitis; conjunctivitis; animal exposure; ocular disease

• Wydawca: -
• Czasopismo: Okulistyka Weterynaryjna. e-kwartalnik dla lekarzy i studentów weterynarii
• Rocznik: 2012
• Numer: 2
• Opis fizyczny: http://www.okulistyka-weterynaryjna.pl/numery-archiwalne/rok-2012/58-nr-2-kwiecie-czerwiec-2012/160-feline-herpesvirus-1-ocular-manifestations-diagnosis-and-treatment-options

Twórcy

autor

Gould D.

• Manor Farm Business Park, Higham Gobion, Hertfordshire, SG5 3HR U.K.

Bibliografia

• Maggs DJ, Lappin MR, Reif JS, Collins JK, Carman J, Dawson DA, Bruns C. Evaluation of serologic and viral detection methods for diagnosing feline herpesvirus-1 infection in cats with acute respiratory tract or chronic ocular disease. J Am Vet Med Assoc 1999; 214: 502-7
• Gaskell RM, Povey RC. Experimental induction of feline viral rhinotracheitis virus re-excretion in FVR-recovered cats. Vet Rec 1977; 12: 128-33
• Stiles. Feline herpesvirus. Infectious disease and the eye. Vet Clin North Am Small Anim Prac 2000; 30: 1001-14
• Stiles J and Townsend WM. Feline Ophthalmology. In: Gelatt KN, ed. Veterinary Ophthalmology 4th edn. Blackwell Publishing, Iowa, 2007: 1095-164
• Gaskell RM, Povey RC. Feline viral rhinotracheitis: Sites of virus replication and persistence in acutely and persistently infected cats. Res Vet Sci 1979; 27: 167-74
• Nasisse MP, Guy JS, Davidson MG, Sussman WA, Fairley NM. Experimental ocular herpesvirus infection in the cat. Sites of virus replication, clinical features and effects of corticosteroid administration. Invest Ophth Vis Sci 1989; 30: 1758-68
• Gaskell, Dennis PE, Goddard LE, Cocker FM, Wills JM. Isolation of felid herpesvirus 1 from the trigeminal ganglia of latently infected cats. J Gen Virol 1985; 66: 391-4
• Ohmura Y, Ono E, Matsuura, Kida H, Shimizu Y. Detection of feline herpesvirus 1 transcripts in trigeminal ganglia of latently infected cats. Arch Virol 1993; 129; 341-7
• Bloom DC. HSV-1 latency and the role of the LATs. In: Sandri-Goldin RM, ed. Alpha Herpesviruses: Molecular and Cellular Biology. Caister Academic Press, 2006; 325-42
• Townsend WM, Stiles J, Guptill-Yoran L, Krohne SG. Development of a reverse transcriptasepolymerase chain reaction assay to detect feline herpesvirus-1 latency-associated transcripts in the trigeminal ganglia and corneas of cats that did not have clinical signs of ocular disease. Am J Vet Res 2004; 65: 314-9
• Galle LE, Moore CP. Clinical Microbiology. In: Gelatt KN, Ed. Veterinary Ophthalmology 4th Edn. Blackwell Publishing, Iowa, 2007: 236-70
• Maggs DJ, Chang E, Nasisse MP, Mitchell WJ. Persistence of herpes simplex virus type 1 DNA in chronic conjunctival and eyelid lesions of mice. J Virol 1998; 72: 9166-72
• English RV. Immune responses and the eye. In: Gelatt KN, ed. Veterinary Ophthalmology 2nd Edn. Lippincott Williams and Wilkins, Baltimore, 1999: 239-58
• Lafon M. Latent viral infections of the nervous system: role of the host immune response. Rev Neurol 2009; 165:1039-44
• Bistner SI, Carlson JH, Shively JN, Scott FW. Ocular manifestations of feline herpesvirus infection. J Am Vet Med Assoc 1971; 159: 1223-37
• Nasisse MP, Guy JS, Stevens JB, English RV, Davidson MG. Clinical and laboratory findings in chronic conjunctivitis in cats: 91 cases (1983-1991). J Am Vet Med Assoc 1993; 203: 834-37
• Nasisse MP, English RV, Tompkins MB, Guy JS, Sussman W. Immunologic, histologic, and virologic features of herpesvirus-induced stromal keratitis in cats. Am J Vet Res 1995; 56: 51-5
• Morgan RV. Feline corneal sequestration: A retrospective study of 42 cases (1987-1991). J Am An Hosp Assoc 1994; 30: 24-28
• Stiles J, McDermott M, Bigsby D, Willis M, Martin C, Roberts W, Greene C. Use of nested polymerase chain reaction to identify feline herpesvirus in ocular tissue from clinically normal cats and cats with corneal sequestra or conjunctivitis. Am J Vet Res 1997; 58: 338-42
• Nasisse MP, Glover TL, Moore CP, Weigler BJ. Detection of feline herpesvirus 1 DNA in corneas of cats with eosinophilic keratitis or corneal sequestration. Am J Vet Res 1998; 59: 856-58
• Allgoewer I, Schaffer EH, Stockhaus C, Vogtlin A. Feline eosinophilic conjunctivitis. Vet Ophthal 2001; 4: 69-74
• Morgan RV, Abrams KL, Kern TJ. Feline eosinophilic keratitis: a retrospective study of 54 cases (1989-1994). Vet Comp Ophthal 1996; 6: 131-4
• Stiles. Treatment of cats with ocular disease attributable to herpesvirus infection: 17 cases (1983-1993). J Am Vet Med Ass 1995; 5: 599-603
• Lim CC, Reilly CM, Thomasy SM, Kass PH, Maggs DJ. Effects of feline herpesvirus type 1 on tear film break-up time, Schirmer tear test results, and conjunctival goblet cell density in experimentally infected cats. Am J Vet Res 2009; 70: 394-403
• Hargis AM, Ginn PE, Mansell JEKL, Garber RL. Ulcerative facial and nasal dermatitis and stomatitis in cats associated with feline herpesvirus 1. Vet Derm 1999; 10: 267-74
• Liesegang TJ. Classification of herpes simplex virus keratitis and anterior uveitis. Cornea 1999; 18:127-43
• Maggs et al. Detection of feline herpesvirus-specific antibodies and DNA in aqueous humour from cats with or without uveitis. Am J Vet Res 1999; 60: 932-6
• Storey ES, Gerding PA, Scherba G, Schaeffer DJ. Survival of equine herpesvirus-4, feline herpesvirus-1, and feline calicivirus in multidose ophthalmic solutions. Vet Ophthalmol. 2002; 5: 263-7.
• Stiles J, McDermott M, Willis M, Roberts W, Greene C. Comparison of nested polymerase chain reaction, virus isolation, and fluorescent antibody testing for identifying feline herpesvirus in cats with conjunctivitis. Am J Vet Res 1997; 58: 804-7
• Hara M, Fukuyama M, Suzuki Y, Kisikawa S, Ikeda T, Kiuchi A, Tabuchi K. Detection of feline herpesvirus 1 DNA by the nested polymerase chain reaction. Vet Microbiol 1996; 48: 345-52
• Helps C, Reeves N, Egan K, Howard P, Harbour D. Detection of Chlamydophila felis and feline herpesvirus by multiplex real-time PCR analysis. J Clin Microbiol 2003; 41: 2734-6
• Volopich S, Benetka V, Schwendenwein I, Mostl K, Sommerfeld-Stur I, Nell B. Cytological findings, and feline herpesvirus DNA and Chlamydophila felis antigen detection rates in normal cats and cats with conjunctival and corneal lesions. Vet Ophth 2005; 8: 25-32
• Goldschmidt P, Rostane H, Sain-Jean C, Batellier L, Alouch C, Zito E, Bourcier T, Laroche L, Chaumeil C. Effects of topical anaesthetics and fluorescein on the real-time PCR used for the diagnosis of Herpesviruses and Acanthamoeba keratitis. B J Ophth 2006; 90: 1354-6
• Low HC, Powell CC, Veir JK, Hawley JR, Lappin MR. Prevalence of feline herpesvirus 1, Chlamydophila felis and Mycoplasma spp DNA in conjunctival cells collected from cats with and without conjunctivitis. Am J Vet Res 2007; 68: 643-8
• Weigler BJ, Guy JS, Nasisse MP, Hancock SI, Sherry B. Effect of a live attenuated intranasal vaccine on latency and shedding of feline herpesvirus 1 in domestic cats. Arch Virol 1997; 142: 2389-400
• Maggs DJ, Clarke HE. Relative sensitivity of polymerase chain reaction assays used for detection of feline herpesvirus type 1 DNA in clinical samples and commercial vaccines. Am J Vet Res 2005; 66: 1550-5
• Sykes JE, Anderson GA, Studdert VP, Browning GF. Prevalence of feline Chlamydia psittaci and feline herpesvirus 1 in cats with upper respiratory tract disease. J Vet Int Med 1999; 13: 153-62
• Nasisse MP, Guy JS, Davidson MG, Sussman W, De Clercq E. In vitro susceptibility of feline herpesvirus-1 to vidarabine, idoxuridine, trifluridine, acyclovir, or bromovinyldeoxyuridine. Am J Vet Res 1989; 50:158-60
• Galle LE. Antiviral therapy for ocular viral disease. Vet Clin North Am Small Anim Prac 2004; 34:639-53
• Maggs DJ, Clarke HE. In vitro efficacy of ganciclovir, cidofovir, penciclovir, foscarnet, idoxuridine, and acyclovir against feline herpesvirus type-1. Am J Vet Res 2004; 65: 399-403
• Sandmeyer LS, Keller CB, Bienzle D. Effects of cidofovir on cell death and replication of feline herpesvirus-1 in cultured feline corneal epithelial cells. Am J Vet Res 2005; 66: 217-22
• Fontenelle JP, Powell CC, Veir JK, Radecki. Effect of topical ophthalmic application of cidofovir on experimentally induced primary ocular feline herpesvirus-1 infection in cats. Am J Vet Res 2008; 69: 289-93
• Thomasy SM, Maggs DJ, Moulin NK, Stanley SD. Pharmacokinetics and safety of penciclovir following oral administration of famciclovir to cats. Am J Vet Res 2007; 68: 1252-8
• Thomasy SM, Lim CC, Reilly CM, Kass PH, Lappin MR, Maggs DJ. Evaluation of orally administered famciclovir in cats experimentally infected with feline herpesvirus type-1. Am J Vet Res. 2011; 72:85-95
• Malik R, Lessels NS, Webb S, Meek M, Graham PG, Vitale C, Norris JM, Power H. Treatment of feline herpesvirus-1 associated disease in cats with famciclovir and related drugs. J Feline Med Surg 2009; 11: 40-8
• Weiss RC. Synergistic antiviral activities of acyclovir and recombinant huma leucocyte (alpha) interferon on feline herpesvirus replication. Am J Vet Res 1988; 50: 1672-7
• Williams DL, Robinson JC, Lay E, Field H. Efficacy of topical aciclovir for the treatment of feline herpetic keratitis: results of a prospective clinical trial and data from in vitro investigations. Vet Rec 2005;157: 254-7
• Hartley C. Treatment of corneal ulcers. What are the medical options? J Feline Med Surg 2010; 12: 383-97
• Katze MG, He Y, Gale M. Viruses and interferon: A fight for supremacy. Nat Rev Immunol 2002; 2: 675-87
• Cantell K, Pyhälä L. Circulating interferon in rabbits after administration of human interferon by different routes. J Gen Virol 1973; 20: 97-104
• Tompkins WA. Immunomodulation and therapeutic effects of the oral use of interferon-alpha: mechanism of action. J Int Cyt Res 1999; 19: 817-28
• Dec M, Puchalski A. Use or oromucosally administered interferon-α in the prevention and treatment of animal diseases. Pol J Vet Sci 2008; 11: 175-86
• Cummins JM, Krakowka GS, Thompson CG. Systemic effects of interferons after oral administration in animals and humans. Am J Vet Res 2005; 66: 164-76
• Bracklein T, Theise S, Metzler A, Spiess BM, Richter M. Activity of feline interferon-omega after ocular or oral administration in cats as indicated by Mx protein expression in conjunctival and white blood cells. Am J Vet Res 2006; 67: 1025-32
• Siebeck N, Hurley DJ, Garcia M, Greene CE, Köstlin RG, Moore PA, Dietrich UM. Effects of human recombinant alpha-2b interferon and feline recombinant omega interferon on in vitro replication of feline herpesvirus-1. Am J Vet Res 2006; 67: 1406-11
• Sandmeyer LS, Keller CB, Bienzle D. Effects of interferon-alpha on cytopathic changes and titers for feline herpesvirus-1 in primary cultures of feline corneal epithelial cells. Am J Vet Res 2005; 66:210-6
• Nasisse MP, Halenda RM, Luo H. Efficacy of low dose oral, natural human interferon alpha in acute feline herpesvirus-1 (FHV-1) infection: A preliminary dose determination trial. Trans Am Coll Vet Ophthal 1996; 27: 79
• Haid C, Kaps S, Gönczi E, Hässig M, Metzler A, Spiess BM, Richter M. Pretreatment with feline interferon omega and the course of subsequent infection with feline herpesvirus in cats. Vet Ophthal 2007; 10: 278-84
• Verneuil M Topical application of feline interferon omega in the treatment of herpetic keratitis in the cat: Preliminary study. Vet Ophthal 2004; 7: 427
• Jongh O. A cat with herpetic keratitis (primary stage of infection) treated with feline omega interferon. In Veterinary Interferon Handbook 2004, Virbac: 138-42
• Jongh O. A cat with a relapse of herpetic keratitis treated with feline omega interferon. In Veterinary Interferon Handbook 2004, Virbac: 143-7
• Thiry E, Addie D, Belák S, Boucraut-Baralon C, Egberink H, Frymus T, Gruffydd-Jones T, Hartmann K, Hosie MJ, Lloret A, Lutz H, Marsilio F, Pennisi MG, Radford AD, Truyen U, Horzinek MC. Feline herpesvirus infection. ABCD guidelines on prevention and management. J Fel Med Surg 2009; 11: 547-55
• Kumar P, Batta R, LaBine G, Shen J, Gaspar K, Docherty J, Foldvari M. Stabilization of Interferon alpha-2b in a Topical Cream. Pharm Tech 2009; 33: 80-86
• Tankersley RW. Amino acid requirements of herpes simplex virus in human cells. J Bact 1964; 87:609-13
• Maggs DJ, Collins BK, Thorne JG, Nasisse MP. Effects of L-lysine and L-arginine on in vitro replication of feline herpesvirus type-1. Am J Vet Res 2000; 61: 1474-8
• Griffith RS, Norins AL, Kagan C. A multicentered study of lysine therapy in herpes simplex infection. Dermatologica 1978; 156: 257-67
• Stiles J, Townsend WM, Rogers QR, Krohne SG. Effect of oral administration of L-lysine on conjunctivitis caused by feline herpesvirus in cats. Am J Vet Res 2002; 63: 99-103
• Maggs DJ, Nasisse MP, Kass PH. Efficacy of oral supplementation with L-lysine in cats latently infected with feline herpesvirus. Am J Vet Res 2003; 64: 37-42
• Maggs DJ, Sykes JE, Clarke HE, Yoo SH, Kass PH, Lappin MR, Rogers QR, Waldron MK, Fascetti AJ. Effects of dietary lysine supplementation in cats with enzootic upper respiratory disease. J Feline Med Surg 2007; 9: 97-108
• Rees TM, Lubinski JL. Oral supplementation with L-lysine did not prevent upper respiratory infection in a shelter population of cats. J Feline Med Surg 2008; 10: 510-3
• Drazenovich TL, Fascetti AJ, Westermeyer HD, Sykes JE, Bannasch MJ, Kass PH, Hurley KF, Maggs DJ. Effects of dietary lysine supplementation on upper respiratory and ocular disease and detection of infectious organisms in cats within an animal shelter. Am J Vet Res 2009; 70: 1391-400
• Lappin MR, Veir JK, Satyaraj E, Czarnecki-Maulden G. Pilot study to evaluate the effect of oral supplementation of Enterococcus faecium SF68 on cats with latent feline herpesvirus 1. J Feline Med Surg; 11: 650-4
• Veir JK, Knorr R, Cavadini C, Sherrill SJ, Benyacoub J, Satyaraj E, Lappin MR. Effect of supplementation with Enterococcus faecium (SF68) on immune functions in cats. Vet Ther 2007; 8:229-38